BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 24116173)

  • 1. A novel heavy domain antibody library with functionally optimized complementarity determining regions.
    Mandrup OA; Friis NA; Lykkemark S; Just J; Kristensen P
    PLoS One; 2013; 8(10):e76834. PubMed ID: 24116173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human combinatorial antibody library HuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies.
    Rothe C; Urlinger S; Löhning C; Prassler J; Stark Y; Jäger U; Hubner B; Bardroff M; Pradel I; Boss M; Bittlingmaier R; Bataa T; Frisch C; Brocks B; Honegger A; Urban M
    J Mol Biol; 2008 Feb; 376(4):1182-200. PubMed ID: 18191144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A large human domain antibody library combining heavy and light chain CDR3 diversity.
    Chen W; Zhu Z; Feng Y; Dimitrov DS
    Mol Immunol; 2010 Jan; 47(4):912-21. PubMed ID: 19883941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.
    Sidhu SS; Li B; Chen Y; Fellouse FA; Eigenbrot C; Fuh G
    J Mol Biol; 2004 Apr; 338(2):299-310. PubMed ID: 15066433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDR-H3 diversity is not required for antigen recognition by synthetic antibodies.
    Persson H; Ye W; Wernimont A; Adams JJ; Koide A; Koide S; Lam R; Sidhu SS
    J Mol Biol; 2013 Feb; 425(4):803-11. PubMed ID: 23219464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction of a large phage-displayed human antibody domain library with a scaffold based on a newly identified highly soluble, stable heavy chain variable domain.
    Chen W; Zhu Z; Feng Y; Xiao X; Dimitrov DS
    J Mol Biol; 2008 Oct; 382(3):779-89. PubMed ID: 18687338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-affinity human antibodies from phage-displayed synthetic Fab libraries with a single framework scaffold.
    Lee CV; Liang WC; Dennis MS; Eigenbrot C; Sidhu SS; Fuh G
    J Mol Biol; 2004 Jul; 340(5):1073-93. PubMed ID: 15236968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions.
    Maruthachalam BV; El-Sayed A; Liu J; Sutherland AR; Hill W; Alam MK; Pastushok L; Fonge H; Barreto K; Geyer CR
    Chembiochem; 2017 Nov; 18(22):2247-2259. PubMed ID: 28884521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a human antibody domain (VH) library.
    Chen W; Zhu Z; Xiao X; Dimitrov DS
    Methods Mol Biol; 2009; 525():81-99, xiii. PubMed ID: 19252835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.
    Barrios Y; Jirholt P; Ohlin M
    J Mol Recognit; 2004; 17(4):332-8. PubMed ID: 15227640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design of a human synthetic combinatorial library of single-chain antibodies.
    Nahary L; Benhar I
    Methods Mol Biol; 2009; 525():61-80, xiv. PubMed ID: 19252839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing CDRH3 diversity captured from secondary lymphoid organs for the generation of recombinant human antibodies.
    Venet S; Kosco-Vilbois M; Fischer N
    MAbs; 2013; 5(5):690-8. PubMed ID: 23924800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Human scFv Library with Non-Combinatorial Synthetic CDR Diversity.
    Bai X; Kim J; Kang S; Kim W; Shim H
    PLoS One; 2015; 10(10):e0141045. PubMed ID: 26484868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Augmented Binary Substitution: Single-pass CDR germ-lining and stabilization of therapeutic antibodies.
    Townsend S; Fennell BJ; Apgar JR; Lambert M; McDonnell B; Grant J; Wade J; Franklin E; Foy N; Ní Shúilleabháin D; Fields C; Darmanin-Sheehan A; King A; Paulsen JE; Hickling TP; Tchistiakova L; Cunningham O; Finlay WJ
    Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15354-9. PubMed ID: 26621728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of CDR3 to V H H domain stability and the design of monobody scaffolds for naive antibody libraries.
    Bond CJ; Marsters JC; Sidhu SS
    J Mol Biol; 2003 Sep; 332(3):643-55. PubMed ID: 12963373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody VH and VL recombination using phage and ribosome display technologies reveals distinct structural routes to affinity improvements with VH-VL interface residues providing important structural diversity.
    Groves MA; Amanuel L; Campbell JI; Rees DG; Sridharan S; Finch DK; Lowe DC; Vaughan TJ
    MAbs; 2014; 6(1):236-45. PubMed ID: 24256948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a scFv Library with Synthetic, Non-combinatorial CDR Diversity.
    Bai X; Shim H
    Methods Mol Biol; 2017; 1575():15-29. PubMed ID: 28255872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Building novel binding ligands to B7.1 and B7.2 based on human antibody single variable light chain domains.
    van den Beucken T; van Neer N; Sablon E; Desmet J; Celis L; Hoogenboom HR; Hufton SE
    J Mol Biol; 2001 Jul; 310(3):591-601. PubMed ID: 11439026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability and CDR composition biases enrich binder functionality landscapes.
    Hackel BJ; Ackerman ME; Howland SW; Wittrup KD
    J Mol Biol; 2010 Aug; 401(1):84-96. PubMed ID: 20540948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic Engineering of Optimized Autonomous Heavy-Chain Variable Domains.
    Nilvebrant J; Ereño-Orbea J; Gorelik M; Julian MC; Tessier PM; Julien JP; Sidhu SS
    J Mol Biol; 2021 Oct; 433(21):167241. PubMed ID: 34508727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.